Allergan haven’t announced it yet, but it seems pretty clear that they are planning to use the brand name Azultro for their oxymetazoline based treatment for the erythema of rosacea.
Azultro started life as V-101 when owned by Vicept Therapeutics. It was renamed as AGN-199201 after Allergan purchased Vicept. Actavis now owns Allergan.
I had a bit of a punt and guessed correctly (and broke the news) that Galderma would use Mirvaso for their brimonidine based redness treatment.
So I’m going to try and make it 2 from 2. you read it here first – get ready for Azultro for the treatment of a red face.
Update – Rhofade it is
Well I jumped the gun and guessed wrong. Allergan have announced that they will using the brand name Rhofade for their oxymetazoline treatment.
